Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Battling HIV/AIDS [[electronic resource] ] : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Taylor
| Battling HIV/AIDS [[electronic resource] ] : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Taylor |
| Autore | Tayler Yolanda <1957-> |
| Pubbl/distr/stampa | Washington, DC, : World Bank, 2004 |
| Descrizione fisica | xxv, 152 p |
| Disciplina | 362.196/9792061 |
| Soggetto topico |
Antiretroviral agents - Purchasing
AIDS (Disease) - Chemotherapy - Economic aspects HIV infections - Chemotherapy - Economic aspects Pharmaceutical industry - Developing countries Pharmaceutical policy - Developing countries |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-08422-7
9786610084227 1-4175-2616-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910455954303321 |
Tayler Yolanda <1957->
|
||
| Washington, DC, : World Bank, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Battling HIV/AIDS : : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Tayler, editor
| Battling HIV/AIDS : : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Tayler, editor |
| Autore | Tayler Yolanda <1957-> |
| Pubbl/distr/stampa | Washington, DC : , : World Bank, , [2004] |
| Descrizione fisica | xxv, 152 pages : illustrations ; ; 23 cm |
| Disciplina | 362.196/9792061 |
| Altri autori (Persone) | TaylerYolanda <1957-> |
| Soggetto topico |
Antiretroviral agents - Purchasing
AIDS (Disease) - Chemotherapy - Economic aspects HIV infections - Chemotherapy - Economic aspects Pharmaceutical industry - Developing countries Pharmaceutical policy - Developing countries |
| ISBN |
1-280-08422-7
9786610084227 1-4175-2616-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910780591803321 |
|
Tayler Yolanda <1957->
|
||
| Washington, DC : , : World Bank, , [2004] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Battling HIV/AIDS : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Taylor
| Battling HIV/AIDS : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Taylor |
| Autore | Tayler Yolanda <1957-> |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, DC, : World Bank, 2004 |
| Descrizione fisica | xxv, 152 pages : illustrations ; ; 23 cm |
| Disciplina | 362.196/9792061 |
| Soggetto topico |
Antiretroviral agents - Purchasing
AIDS (Disease) - Chemotherapy - Economic aspects HIV infections - Chemotherapy - Economic aspects Pharmaceutical industry - Developing countries Pharmaceutical policy - Developing countries |
| ISBN |
1-280-08422-7
9786610084227 1-4175-2616-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- Foreword -- Executive Summary -- Preface -- Acknowledgments -- Abbreviations -- 1 Challenges in Scaling up Treatment -- The economic impact of HIV/AIDS and ART -- Estimating resource requirements -- Long-term economic effect of HIV/AIDS and other considerations -- 2 Intellectual Property Rights: A Concise Guide -- Introduction to this concise guide -- How patents affect medicines procurement -- Least developed countries -- Developing countries -- A note on "parallel imports" -- Registration and data exclusivity -- 3 Managing the Supply Cycle for Better Outcomes -- Who does what? -- What tasks need to be done? -- Who is already carrying out these tasks? -- Monitoring procurement results -- 4 Product Selection, Quantification, and Quality Assurance -- Product selection -- How drugs should be selected for HIV-related treatment -- Product quantification -- Quality assurance and supplier selection -- Testing and laboratory capacity -- 5 Procurement -- Assessing capacity -- Commodities that support the HIV/AIDS program -- Planning procurement -- Registering products -- Choosing procurement methods -- 6 Pricing -- What determines drug prices? -- Additional price determinants in retail markets -- How can public purchasers bargain for low prices? -- Annex A. Estimating Resource Requirements for AIDS Treatment -- Annex B. Intellectual Property Rights: How They Affect Procurement and What Steps Can Be Taken -- Annex C. HIV Test Kits and Other Diagnostics -- Glossary -- Index -- Boxes -- 1.1 The long-term economic consequences of AIDS in South Africa -- 1.2 ART and drug resistance -- 3.1 Who can help in selection and quantification? -- 3.2 Who can help with regulatory issues of product registration, intellectual property, and import? -- 3.3 Who can help with procurement? -- 3.4 Who can help with storage and distribution?.
4.1 Useful references for quantification -- 5.1 Social marketing: another way to distribute -- 5.2 Useful references on procurement -- 6.1 Examples of pooled procurement initiatives -- 6.2 Sources of information on production costs and prices -- 6.3 Evidence of equity pricing for ARVs -- B.1 Parallel importing -- B.2 Parallel imports in South Africa-under the rule of international exhaustion -- Figures -- 2.1 Intellectual property rights checklist: least developed country -- 2.2 Intellectual property rights checklist: developing country -- 2.3 Can a country use World Bank funds to procure generic ARVs? -- 3.1 The medicines supply cycle -- 3.2 Tasks and stages of the supply cycle -- 5.1 Commodities that support the HIV/AIDS program -- 5.2 Procurement flowchart -- 6.1 Pharmaceutical supply chain -- 6.2 Drug procurement and options for lowering prices -- Tables -- 4.1 WHO recommendations for initiating ART in adults and adolescents with documented HIV infection -- 4.2 WHO first-line ARV regimens in adults and adolescents and characteristics that can influence choice -- 4.3 Quantification methods -- 4.4 Calculating procurement quantities -- 4.5 Multisource and single- and limited-source products -- A.1 People living with HIV/AIDS in Burkina Faso, 2003-10 -- A.2 Projected cost of ART (drugs only) for all people with AIDS under high cost (1,000), low cost (333), and lowest cost ( -- A.3 Projected total cost of ART, per person per year, 2003 -- A.4 Projected total cost of ART for all people with AIDS in Burkina Faso, under high cost (1,730) and lowest cost (620) price scenarios, 2003-10 -- A.5 Projected number of people living with HIV/AIDS in Kenya and South Africa, 2002-10 -- A.6 Projected cost of ART (drugs only) for all people with AIDS in Kenya, under high cost (1,000), low cost (333), and lowest cost (140) price scenarios, 2002-10. A.7 Projected cost of ART (drugs only) for all people with AIDS in South Africa, under high cost (1,000), low cost (333), and lowest cost (140) price scenarios, 2002-10 . -- A.8 Projected total costs of ART, per person per year, in Kenya and South Africa. |
| Record Nr. | UNINA-9910807336503321 |
|
Tayler Yolanda <1957->
|
||
| Washington, DC, : World Bank, 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||